Gregory A Wiseman

Gregory A Wiseman

UNVERIFIED PROFILE

Are you Gregory A Wiseman?   Register this Author

Register author
Gregory A Wiseman

Gregory A Wiseman

Publications by authors named "Gregory A Wiseman"

Are you Gregory A Wiseman?   Register this Author

57Publications

1320Reads

32Profile Views

Outcome prediction in heart failure with atrial fibrillation: relative role of left ventricular ejection fraction and neurohormonal measures.

J Nucl Cardiol 2013 Oct 9;20(5):821-9. Epub 2013 Jul 9.

Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12350-013-9751-x
Publisher Site
http://dx.doi.org/10.1007/s12350-013-9751-xDOI Listing
October 2013

The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma.

J Am Acad Dermatol 2012 Dec 30;67(6):1250-6. Epub 2012 Apr 30.

Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2012.03.018DOI Listing
December 2012

Progress in gene therapy for prostate cancer.

Front Oncol 2012 19;2:172. Epub 2012 Nov 19.

Department of Radiation Oncology, Mayo Clinic Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2012.00172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500761PMC
November 2012

The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.

Mol Imaging Biol 2010 Oct 1;12(5):547-53. Epub 2009 Dec 1.

Division of Nuclear Medicine, Department of Radiology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-009-0276-2DOI Listing
October 2010

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.

Pancreas 2010 Aug;39(6):713-34

Eastern Virginia Medical School, Strelitz Diabetes Center for Endocrine and Metabolic Disorders, Norfolk, VA 3510, USA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00006676-201008000-0000
Publisher Site
http://dx.doi.org/10.1097/MPA.0b013e3181ebaffdDOI Listing
August 2010

18F-FDG PET and PET/CT in Burkitt's lymphoma.

Eur J Radiol 2010 Jul 27;75(1):e68-73. Epub 2009 Aug 27.

Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2009.07.035DOI Listing
July 2010

Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma.

J Nucl Med 2010 Jan 15;51(1):150-7. Epub 2009 Dec 15.

Department of Radiation Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.109.066597DOI Listing
January 2010

Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma.

J Vasc Interv Radiol 2009 Nov;20(11):1460-3

Department of Radiology, Division of Vascular and Interventional Radiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2009.07.033DOI Listing
November 2009

18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.

Thyroid 2008 Jul;18(7):713-9

Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2007.0350DOI Listing
July 2008

Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT.

J Comput Assist Tomogr 2007 Sep-Oct;31(5):800-5

Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0b013e3180340376DOI Listing
November 2007

18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.

Nucl Med Commun 2007 Nov;28(11):834-41

Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0b013e328264ae7fDOI Listing
November 2007

Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphoma.

Cancer Biother Radiopharm 2007 Oct;22(5):684-91

Division of Hematology/Oncology, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2007.359DOI Listing
October 2007

Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.

J Nucl Med 2007 Jun 15;48(6):896-901. Epub 2007 May 15.

Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.106.039024DOI Listing
June 2007

Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy.

Cancer 2006 Jul;107(2):433-8

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21998DOI Listing
July 2006

Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism.

World J Surg 2006 Mar;30(3):327-32

Department of Surgery, Mayo Clinic, 200 Second Street SW, Rochester, Minnesota 55901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-005-0279-3DOI Listing
March 2006

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma.

J Clin Oncol 2003 Apr;21(7):1263-70

Division of Internal Medicine and Hematology and the Department of Radiology, Nuclear Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.08.043DOI Listing
April 2003

Additional radiation absorbed dose estimates for Zevalin radioimmunotherapy.

Cancer Biother Radiopharm 2003 Apr;18(2):253-8

Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/108497803765036436DOI Listing
April 2003

Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.

J Clin Oncol 2002 Sep;20(18):3885-90

Divisions of Hematology and Nuclear Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.10.143DOI Listing
September 2002

Assessment of Lymphoma Therapy Using (18)F-FDG PET.

J Nucl Med 2002 Aug;43(8):1028-30

PET Imaging, Department of Radiology, Mayo Clinic Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
August 2002

Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.

J Clin Endocrinol Metab 2002 Apr;87(4):1521-6

Division of Endocrinology, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem.87.4.8373DOI Listing
April 2002

Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody.

J Nucl Med 2002 Feb;43(2):267-72

School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
February 2002

Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma.

Cancer 2002 Feb;94(4 Suppl):1349-57

Division of Nuclear Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.10305DOI Listing
February 2002